Lei Li

机构：First Affiliated Hospital of Xi'an Jiaotong University · ORCID：0000-0001-6199-8263

发表论文 16 篇 · 总被引 110 次 · h-index 5

代表论文

• MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation (2024 · Nature Communications · 被引 43)
• ATP-citrate lyase controls endothelial gluco-lipogenic metabolism and vascular inflammation in sepsis-associated organ injury (2023 · Cell Death and Disease · 被引 41)
• DTX3L-mediated TIRR nuclear export and degradation regulates DNA repair pathway choice and PARP inhibitor sensitivity (2024 · Nature Communications · 被引 9)
• A Peptide-Based PROTAC Degrader of BRCA2 Sensitizes Metastatic Castration-Resistant Prostate Cancer to PARP Inhibition (2025 · Cancer Research · 被引 7)
• CK2-dependent degradation of CBX3 dictates replication fork stalling and PARP inhibitor sensitivity (2024 · Science Advances · 被引 7)
• FBXO22 is a potential therapeutic target for recurrent chondrosarcoma (2024 · Journal of bone oncology · 被引 3)